Contraceptives Market

Contraceptives Market Study by Contraceptive Drugs and Contraceptive Devices for Hospital Pharmacies, Independent Pharmacies, Online Platforms, and Clinics from 2023 to 2033

Analysis of Contraceptives Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Contraceptives Market Outlook (2023 to 2033)

Global demand for contraceptives is predicted to increase at a CAGR of 6.5% from 2023 to 2033. As a result, the global contraceptives market size is set to increase from a value of US$ 33 billion to US$ 62 billion by the end of 2033.

The use of contraceptive devices is being driven by robust government campaigns and programs for women's and children's health. Women who do not want to utilize the hormonal form to prevent potential adverse effects typically prefer copper intrauterine devices (IUDs).

A way of preventing pregnancy known as contraception uses medication or a device. It is sometimes referred to as fertility control or birth control. Pregnancy during intercourse is prevented by the use of contraception. There are various contraceptive methods available; the most effective one depends on one's health and situation. To prevent conception, contraceptive methods or medications disrupt the normal sperm-ovum fertilization process.

Contraception prevents pregnancy by interfering with the natural processes of fertilization, ovulation, and implantation through the use of medications, medical devices, and surgical procedures. Contraceptive medicines also prevent sexually transmitted diseases (STDs). Contraceptive devices, which are primarily composed of plastic or metal, come in a variety of shapes, including loop, coil, T-shaped, and triangle.

Key factors influencing the market are the increased development of effective female contraceptive drugs and devices, technological advancements, an increase in government and non-governmental organization initiatives to promote contraceptives, and the implementation of the Patient Protection Act. The growing prevalence of sexually transmitted diseases and the need for population control are the factors driving market growth.

The market is anticipated to be driven by the implementation of efforts aiming at reducing unintended births and the ensuing development in user awareness levels. Along with these factors, the rise in the use of oral tablets as a primary method of contraception and the health problems connected to teenage pregnancies are fueling market growth.

The fundamental right to privacy guaranteed by the United States Constitution includes the ability to obtain and use contraceptives. The development of emergency oral contraceptive tablets is just one example of the numerous technological advancements in contraceptive medications that have fueled industry expansion.

Older combined oral contraceptives (COCs) containing 50 micrograms of estrogen have mainly been replaced by low-dose COCs containing 20–35 micrograms of ethinylestradiol in combination with progestogen. Because there is a lesser chance of venous thromboembolism, low-dose COCs are preferred. A good growth trajectory will be strongly suggested by the increase in clinical studies relevant to birth control methods for enhanced efficacy throughout the forecast period.

Report Attributes


Contraceptives Market Size (2023)

US$ 33 Billion

Projected Market Value (2033)

US$ 62 Billion

Global Market Growth Rate (2023 to 2033)

6.5% CAGR

Market Share of Contraceptive Devices


Key Companies Profiled

  • Evofem Biosciences
  • CooperSurgical, Inc.
  • Actavis, Inc.
  • Medisafe Distribution Inc.
  • Mayer Laboratories, Inc.
  • Mylan
  • Allergan Plc.
  • Veru Inc.
  • CooperSurgical, Inc.
  • Pfizer Inc.

Why are Sales of Contraceptives Increasing Rapidly across Regions?

“Rise in Unwanted Pregnancies and Growing Prevalence of Sexually Transmitted Diseases”

Most unwanted pregnancies occur among adolescents and young women. Such pregnancies are a major source of the prevalence of sexually transmitted diseases (STDs) such as HIV, chlamydia, genital herpes, and hepatitis B.

With this ever-increasing risk, there is a rise in awareness about modern contraceptives. Governments from different countries are conducting major campaigns and sex education programs to raise youth awareness and encourage the use of contraception to prevent STDs and unintended births.

Increased demand for sexual and reproductive health services as well as contemporary contraception methods are being met by several government initiatives. All steps of these health services' evaluation, implementation, and planning should involve children, teenagers, and women.

Since many women now prioritize their careers over having children, many are delaying motherhood. In addition to the rising prevalence of unstable relationships and worries about job safety, more women are becoming aware of the costs incurred when raising children. The market for contraceptives is projected to expand as people become more aware of the need of making the right decisions regarding their sexual and reproductive health.

The World Health Organization collaborates with partners at the international, regional, and national levels to strengthen and enhance family planning and reproductive health outcomes. To address the unmet need for family planning, these partnerships will streamline family planning programs, increase access to contraceptive technologies and supplies, and mobilize international commitments. Human rights are becoming a more important consideration for contraceptive services and programs.

Additionally, the health risks connected to young pregnancies, a rise in the use of oral tablets as a primary method of contraception, and increased awareness of modern contraception all contribute to market expansion. Business revenue will be favorably impacted by supportive family planning policies as well as other reimbursement policies such as the AIDS care policy.

Other trends, notably the introduction of new, innovative, and low-cost contraceptive devices by key market players are also expected to significantly leverage the contraceptives market. For instance, Agile Therapeutics is performing a stage 3 trial for Twirla, a contraceptive patch designed to deliver a low daily dose of estrogen.

Don't Need a Global Report?

save 40%! on Country & Region specific reports

What is Hampering Global Demand Growth for Contraceptives?

“Side Effects Related to Use of Contraceptives and Lack of Societal Acceptance”

The contraceptives market could be negatively impacted by the side effects related to the use of contraceptives, the availability of alternative contraceptive methods, and a lack of societal acceptance. Pricing trends indicate that the high costs of some contraceptive devices are hampering market growth.

Contraceptives Market Size, Share & Growth Forecast by Fact.MR

How are Emerging Market Players Penetrating This Industry?

“New Companies Introducing Modern & Fast-reacting Contraceptives Without Side Effects”

Upcoming market players are focusing on quality control of products and new developments in biotechnology such as targeted medication to broaden their market footprint. Start-ups are creating modern contraceptives that let women plan their families without risky side effects.

  • OUI is a vaginal capsule made by the Danish start-up Cirqle Biomedical that dissolves quickly and releases its formulation when inserted. Within a minute of delivering OUI, the start-up claims effective contraception without negative side effects.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Which Region Accounts for a Leading Position in the Contraceptives Market?

“Huge Demand for Reversible Contraceptives in North America”

North America accounts for 50% share of the global market owing to the growing prevalence of unintended pregnancies, rising demand for reversible contraceptives, and public sector initiatives to provide funding for family planning and contraception. High abortion rates and the introduction of generic and affordable medications and devices, and the presence of top contraceptive suppliers are fueling market value in the region.

Country-wise Insights

Why is the United States Considered a Profitable Market for Contraceptive manufacturers?

“Rising Rate of Teenage Pregnancies in the Country

One of the top producers and consumers of contraceptives worldwide is the United States. The market in the United States is anticipated to experience rapid growth due to the existence of advanced medical facilities, the high acceptance rate of contraceptive medications, and well-established distribution channels.

The majority of the female population in the country is of reproductive age. Additionally, the rising rate of teenage pregnancies in the United States will support regional expansion.

How is Demand for Contraceptives Evolving in Germany?

“Favorable Reimbursement Policies for Use of Contraceptives”

An increase in financing for clinical trials of modern birth control drugs and favorable reimbursement policies for the use of contraceptives are the elements supporting market expansion in Germany.

What is Benefitting Manufacturers of Contraceptives in Japan?

“Expanding Government Initiatives to Increase Public Awareness of Family Planning”

Japan is emerging as a burgeoning market for contraceptives. The high incidence of the spread of STDs due to a rapidly expanding population is a key motivator for market growth. Expanding government initiatives to increase public awareness of family planning and women's health and a rise in the local supply of external physical barriers such as condoms are the factors boosting market expansion.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Category-wise Insights

Why are Contraceptive Devices Gaining Immense Popularity?

“Contraceptive Devices Gaining Traction Due to Their Excellent Efficacy in Regular Monitoring of Women's Health

Based on product, the market is divided into contraceptive devices and contraceptive drugs. Contraceptive devices account for 50% share of the global market due to the increasing product approvals to meet the escalating demand for such medical devices, as well as their excellent efficacy in regular monitoring of women's health.

Contraceptive devices are gaining traction owing to the major side effects of ingesting contraceptive drugs, particularly among women. These include nausea, headache, weight gain, increased bleeding, dysmenorrhea, and menstrual changes.

Some of the most widely used devices are condoms, diaphragms, sponges, rings, sub-dermal implants, and intrauterine devices (IUDs). The most extensively used product is the condom. Moreover, the introduction of custom-fit condoms by key market players is expected to drive the demand for contraceptive devices.

Which Distribution Channel is Leading the Sales of Contraceptives?

“Hospital Pharmacies More Preferred Owing to Easy Accessibility of Various Contraceptive Products

The market is divided into hospital pharmacies, independent pharmacies, online platforms, clinics, and others on the basis of the distribution channel. Hospital pharmacies are preferred by individuals due to an increase in hospital partnerships with distributors and manufacturers, particularly for birth control devices. The easy accessibility of various contraceptive products, improved supply chain management, and growing public awareness of various birth control tablets are boosting the sales of contraceptives through hospital pharmacies.

Competitive Landscape

Leading companies are concentrating on R&D initiatives to launch modern contraceptive devices following safety regulations to reduce the environmental impact. Top contraceptive providers are involved in acquiring and collaborating with other businesses and enhancing product standards.

For instance,

  • In 2021, Generate Life Sciences was acquired by Cooper Surgical, Inc. Cooper's reproductive section is improved by this acquisition.
  • In 2021, Clue introduced a digital birth control method that provides customers with an ovulation prediction based on statistics.
  • Pfizer Inc’s Sayana Press is the first injectable contraceptive for women available in the U.K. The company is also in the process of conducting a study evaluating levonorgestrel and Ethinyl estradiol as potential oral contraceptives.
  • Merck & Co, Inc., offers contraceptive care in the form of combined oral pills, vaginal rings, intrauterine devices, and sub-dermal implants. Popular products include Cyclessa, Desogen, NuvaRing, Implanon, and Nexplanon.
  • Cipla manufactures oral contraceptives named Crisanta. The medicine contains Drospirenone, which prevents the fertilization of the egg with the sperm. It also induces hormonal changes contributing to the prevention of pregnancy.

Key Segments of Contraceptives Industry Research

  • By Product :

    • Contraceptive Drugs
      • Oral Contraceptives
        • Combined Contraceptives
        • Mini pills
        • Contraceptive Injectable
        • Topical Contraceptive Patch
    • Contraceptive Devices
      • Male Contraceptive Devices
      • Female Contraceptive Devices
        • Female Condoms
        • Contraceptive Diaphragms
        • Contraceptive Sponges
        • Contraceptive Vaginal Rings
        • Intrauterine Devices
        • Sub-dermal Contraceptive Implants
        • Non-surgical Permanent Contraception Devices
  • By Distribution Channel :

    • Hospital Pharmacies
    • Independent Pharmacies
    • Online Platforms
    • Clinics
    • Others
  • By Region :

    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

- FAQs -

What is the market value for contraceptives in 2023?

The global contraceptives market is valued at US$ 33 billion in 2023.

Which contraceptive product accounts for a leading market share?

Contraceptive devices hold 50% share of the global market in 2023.

What is the predicted growth rate for the contraceptives market?

Sales of contraceptives are set to increase at a CAGR of 6.5% through 2033.

Who are the key suppliers of contraceptives?

Evofem Biosciences, CooperSurgical, Inc., and Actavis, Inc. are the top producers of contraceptives.

How big will the market for contraceptives be by 2033?

Worldwide demand for contraceptives is forecasted to reach a market value of US$ 62 billion by 2033.

Contraceptives Market

Schedule a Call